Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,417-1,428 of 1,745
Drug study icon
CompletedNCT05481736

COMP360 Psilocybin Therapy for Eating disorders

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing COMP360 Psilocybin Therapy for Eating disorders.

In United Kingdom
Eating disordersDrugOver 18 Years
Countries
United States, United Kingdom, Ireland
Sponsor
COMPASS Pathways
Condition
Eating disorders
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In United Kingdom
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In United Kingdom
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.